Circassia
Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement
April 9, 2020Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory
Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …
Circassia stumbles with allergy treatments at clinical trial stage, again
April 18, 2017Manufacturing and Production, Research and Development, Sales and Marketing Circassia
Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with …
Circassia appoints new chairman from Biogen Idec
September 26, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Circassia, granata
Speciality biopharma firm Circassia has appointed Dr Francesco Granata as its non-executive chairman. Granata is executive in Residence at Warburg …
Circassia appoints new head to its Board of directors
December 6, 2012Manufacturing and Production, Research and Development, Sales and Marketing Circassia
Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …
Circassia appoints Stewart Sharpe as VP Commercial Operations
September 19, 2012Medical Communications, Research and Development, Sales and Marketing Circassia, Stewart Sharpe
Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. …
Circassia appoints GSK’s Dr Brett Haumann
September 11, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia
Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …
Circassia raises funds to develop allergy products
April 19, 2011Research and Development Circassia, UK biotech, biotech
UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
